Transport of fluorescein methotrexate by multidrug resistance-associated protein 3 in IEC-6 cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 285, Issue 3 48-3, 2003, Pages

  Li, Tiesong ^a   Ito, Kousei ^a   Horie, Toshiharu ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Crypt; Intestine; MRP3

Indexed keywords

ADENOSINE TRIPHOSPHATE; ESTRADIOL 17 GLUCURONIDE; FLUORESCEIN; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; TAUROCHOLIC ACID; VERLUKAST;

ANIMAL CELL; ARTICLE; BASOLATERAL MEMBRANE; CONTROLLED STUDY; DRUG TRANSPORT; INTESTINE CRYPT; LEPIDOPTERA; MEMBRANE VESICLE; MONOLAYER CULTURE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TRANSCYTOSIS;

EID: 0042466167     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00424.2002     Document Type: Article

References (45)

1. Akita H, Suzuki H, Hirohashi T, Takikawa H, and Sugiyama Y. Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3. Pharm Res 19: 34-41, 2002.
2. Assaraf YG. Characterization by flow cytometry and fluorescein-methotrexate labeling of hydrophilic and lipophilic antifolate resistance in cultured mammalian cells. Anticancer Drugs 4: 535-544, 1993.
3. Bera TK, Iavarone C, Kumar V, Lee S, Lee B, and Pastan I. MRP9, an unusual truncated member of the ABC transporter superfamily, is highly expressed in breast cancer. Proc Natl Acad Sci USA 99: 6997-7002, 2002.
4. Borst P, Evers R, Kool M, and Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 92: 1295-1302, 2000.
5. Dixon KH, Lanpher BC, Chiu J, Kelley K, and Cowan KH. A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J Biol Chem 269: 17-20, 1994.
6. Fan J, Pope LE, Vitols KS, and Huennekens FM. Visualization of folate transport proteins by covalent labeling with fluorescein methotrexate. Adv Enzyme Regul 30: 3-12, 1990.
7. Fan JG, Pope LE, Vitols KS, and Huennekens FM. Affinity labeling of folate transport proteins with the N-hydroxysuccinimide ester of the γ-isomer of fluorescein-methotrexate. Biochemistry 30: 4573-4580, 1991.
8. Frei E III, Jaffe N, Tattersall MH, Pitman S, and Parker L. New approaches to cancer chemotherapy with methotrexate. N Engl J Med 292: 846-851, 1975.
9. Gapski GR, Whiteley JM, Rader JI, Cramer PL, Henderson GB, Neef V, and Huennekens FM. Synthesis of a fluorescent derivative of amethopterin. J Med Chem 18: 526-528, 1975.
10. Gutmann H, Miller DS, Droulle A, Drewe J, Fahr A, and Fricker G. P-glycoprotein- and mrp2-mediated octreotide transport in renal proximal tubule. Br J Pharmacol 129: 251-256, 2000.
11. Henderson GB, Russell A, and Whiteley JM. A fluorescent derivative of methotrexate as an intracellular marker for dihydrofolate reductase in L1210 cells. Arch Biochem Biophys 202: 29-34, 1980.
12. Hirohashi T, Suzuki H, Ito K, Ogawa K, Kume K, Shimizu T, and Sugiyama Y. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats. Mol Pharmacol 53: 1068-1075, 1998.
13. Hirohashi T, Suzuki H, and Sugiyama Y. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem 274: 15181-15185, 1999.
14. Hirohashi T, Suzuki H, Takikawa H, and Sugiyama Y. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J Biol Chem 275: 2905-2910, 2000.
15. Hopper E, Belinsky MG, Zeng H, Tosolini A, Testa JR, and Kruh GD. Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily. Cancer Lett 162: 181-191, 2001.
16. Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T, and Sugiyama Y. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol Gastrointest Liver Physiol 272: G16-G22, 1997.
17. Ito K, Suzuki H, and Sugiyama Y. Charged amino acids in the transmembrane domains are involved in the determination of the substrate specificity of rat Mrp2. Mol Pharmacol 59: 1077-1085, 2001.
18. Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, and Chabner BA. The pharmacology and clinical use of methotrexate. N Engl J Med 309: 1094-1104, 1983.
19. Jolivet J, Faure MP, Wong SC, Taub JW, and Matherly LH. Confocal microscopy visualization of antifolate uptake by the reduced folate carrier in human leukaemic cells. Br J Cancer 76: 734-738, 1997.
20. Kao HH, Huang JD, and Chang MS. cDNA cloning and genomic organization of the murine MRP7, a new ATP-binding cassette transporter. Gene 286: 299-306, 2002.
21. Konig J, Nies AT, Cui Y, Leier I, and Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1461: 377-394, 1999.
22. Konig J, Rost D, Cui Y, and Keppler D. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29: 1156-1163, 1999.
23. Kool M, van der Linden M, de Haas M, Scheffer GL, de Vree JM, Smith AJ, Jansen G, Peters GJ, Ponne N, Scheper RJ, Elferink RP, Baas F, and Borst P. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci USA 96: 6914-6919, 1999.
24. Lai L and Tan TM. Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem J 361: 497-503, 2002.
25. Leier I, Jedlitschky G, Buchholz U, Cole SP, Deeley RG, and Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 269: 27807-27810, 1994.
26. Loe DW, Almquist KC, Cole SP, and Deeley RG. ATP-dependent 17 beta-estradiol 17-(beta-v-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. J Biol Chem 271: 9683-9689, 1996.
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
28. Marheineke K, Grunewald S, Christie W, and Reilander H. Lipid composition of Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) insect cells used for baculovirus infection. FEBS Lett 441: 49-52, 1998.
29. Mottino AD, Hoffman T, Jennes L, and Vore M. Expression and localization of multidrug resistant protein mrp2 in rat small intestine. J Pharmacol Exp Ther 293: 717-723, 2000.
30. Nagakubo J, Tomimatsu T, Kitajima M, Takayama H, Aimi N, and Horie T. Characteristics of transport of fluoresceinated methotrexate in rat small intestine. Life Sci 69: 739-747, 2001.
31. Peng KC, Cluzeaud F, Bens M, Van Huyen JP, Wioland MA, Lacave R, and Vandewalle A. Tissue and cell distribution of the multidrug resistance-associated protein (MRP) in mouse intestine and kidney. J Histochem Cytochem 47: 757-768, 1999.
32. Quaroni A, Wands J, Trelstad RL, and Isselbacher KJ. Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol 80: 248-265, 1979.
33. Rajgopal A, Sierra EE, Zhao R, and Goldman ID. Expression of the reduced folate carrier SLC19A1 in IEC-6 cells results in two distinct transport activities. Am J Physiol Cell Physiol 281: C1579-C1586, 2001.
34. Roelofsen H, Vos TA, Schippers IJ, Kuipers F, Koning H, Moshage H, Jansen PL, and Muller M. Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells. Gastroenterology 112: 511-521, 1997.
35. Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, and Huvos AG. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer 43: 2163-2177, 1979.
36. Rost D, Mahner S, Sugiyama Y, and Stremmel W. Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine. Am J Physiol Gastrointest Liver Physiol 282: G720-G726, 2002.
37. Said HM, Nguyen TT, Dyer DL, Cowan KH, and Rubin SA. Intestinal folate transport: identification of a cDNA involved in folate transport and the functional expression and distribution of its mRNA. Biochim Biophys Acta 1281: 164-172, 1996.
38. Seitz M. Molecular and cellular effects of methotrexate. Curr Opin Rheumatol 11: 226-232, 1999.
39. Sierra EE and Goldman ID. Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates. Semin Oncol 26: 11-23, 1999.
40. Soroka CJ, Lee JM, Azzaroli F, and Boyer JL. Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 33: 783-791, 2001.
41. Steck TL, Weinstein RS, Straus JH, and Wallach DF. Inside-out red cell membrane vesicles: preparation and purification. Science 168: 255-257, 1970.
42. Suh E and Traber PG. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol 16: 619-625, 1996.
43. Van Aubel RA, van Kuijck MA, Koenderink JB, Deen PM, van Os CH, and Russel FG. Adenosine triphosphate-dependent transport of anionic conjugates by the rabbit multidrug resistance-associated protein Mrp2 expressed in insect cells. Mol Pharmacol 53: 1062-1067, 1998.
44. Yamaoka K, Tanigawara Y, Nakagawa T, and Uno T. A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn 4: 879-885, 1981.
45. Zeng H, Liu G, Rea PA, and Kruh GD. Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res 60: 4779-4784, 2000.